KARYOPHARM THERAPEUTICS INC - NOTE 3.000%10/1

Q4 2022 13F Holders as of 12/31/2022

Type / Class
Debt / NOTE 3.000%10/1
Number of holders
9
Total Principal
157M
Shares change
-627K
Total reported value, excl. options
$129M
Value change
-$510K
Put/Call ratio
0
Number of buys
1
Number of sells
-1
Price
$0.76
Investor Option Weight % Change % Value $ * Price $ Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.